Mounjaro is a new and exciting injectable medication that is likely be the most effective obesity medication ever, based on the results of the SURMOUNT trial. The recently published SURMOUNT trial established the efficacy of tirzepatide. In this phase 3, controlled study, 2,539 people were randomized to receive either tirzepatide (at 5, 10 or 15 mg) or a placebo. After 72 weeks of treatment, the following results were observed:
-With the placebo, the average weight loss was 3.1 percent.
-With 5 mg tirzepatide, the average weight loss was 15 percent.
-With 10 mg tirzepatide, weight loss increased to 19 percent.
-At 15 mg, the average weight loss was a remarkable 20.9 percent.
(Wegovy, the previous weight loss leader, has an average weight loss of 15 percent.)
Tirzepatide, sold under the brand name of Mounjaro, works in several ways such as helping the body release insulin, removing excess sugar from the blood, helping the liver regulate sugar, reducing how much food is eaten, and slowing down how quickly food leaves the stomach. Overall, this injection will help you lose weight by decreasing your appetite and making you feel full longer.
This once-weekly injection is a promising new treatment option for adults looking to significantly reduce their A1c levels and lose weight. At HCM Aesthetics, we understand that achieving long-term success with weight loss can be difficult. That’s why our team of healthcare professionals provides personalized and comprehensive weight loss treatment plans. We take into account each patient’s unique needs and goals to provide an individualized weight loss plan.
In addition to these approaches, we also offer the latest treatments, such as Mounjaro, that can help to maximize results and ensure a healthier, more sustainable outcome. Our team is committed to providing the highest level of care and support to each one of our patients, and we look forward to helping you reach your weight loss goals.